UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas

Neurology, 2010-10, Vol.75 (17), p.1560-1566

2010

Volltextzugriff (PDF)

Genetic markers predictive of chemosensitivity and outcome in gliomatosis cerebri

Neurology, 2008-02, Vol.70 (8), p.590-595

2008

Volltextzugriff (PDF)

Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome

Neurology, 2007-05, Vol.68 (21), p.1831-1836

2007

Volltextzugriff (PDF)

Gray matter involvement predicts chemosensitivity and prognosis in gliomatosis cerebri

Neurology, 2009-08, Vol.73 (6), p.445-449

2009

Volltextzugriff (PDF)

Correlations between molecular profile and radiologic pattern in oligodendroglial tumors

Neurology, 2004-12, Vol.63 (12), p.2360-2362

2004

Volltextzugriff (PDF)

Epidermal growth factor receptor extracellular domain mutations in primary glioblastoma

Neuropathology and applied neurobiology, 2009-04, Vol.35 (2), p.208-213

2009

Volltextzugriff (PDF)

Supratentorial low-grade gliomas in older patients

Neurology, 2009-12, Vol.73 (24), p.2093-2098

2009

Volltextzugriff (PDF)

Bevacizumab and irinotecan for recurrent oligodendroglial tumors

Neurology, 2009-05, Vol.72 (18), p.1601-1606

2009

Volltextzugriff (PDF)

Ischemic stroke in patients with glioblastoma multiforme

Journal of neurology, 2005-04, Vol.252 (4), p.488-489

2005

Volltextzugriff (PDF)

TP53 codon 72 polymorphism is associated with age at onset of glioblastoma

Neurology, 2009-01, Vol.72 (4), p.332-336

2009

Volltextzugriff (PDF)

Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study

Neuro-oncology (Charlottesville, Va.), 2010-04, Vol.12 (4), p.401-408

2010

Volltextzugriff (PDF)

Polymorphism in Sp1 recognition site of the EGF receptor gene promoter and risk of glioblastoma

Neurology, 2006-09, Vol.67 (5), p.872-874

2006

Volltextzugriff (PDF)

EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastoma

Neuro-oncology (Charlottesville, Va.), 2012-12, Vol.14 (12), p.1503-1510

2012

Volltextzugriff (PDF)

Prognostic impact of molecular markers in a series of 220 primary glioblastomas

Cancer, 2006-05, Vol.106 (10), p.2218-2223

2006

Volltextzugriff (PDF)

Gliomatosis cerebri : a review of 296 cases from the ANOCEF database and the literature

Journal of neuro-oncology, 2006-01, Vol.76 (2), p.201-205

2006

Volltextzugriff (PDF)

Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma

Neuro-oncology (Charlottesville, Va.), 2006-01, Vol.8 (1), p.60

2006

Volltextzugriff (PDF)

Multiple gliomas: clinical studies and pathophysiological hypothesis

Revue neurologique, 2006-09, Vol.162 (8-9), p.845-851

2006

Volltextzugriff (PDF)

Chromosome 1p loss: A favorable prognostic factor in low-grade gliomas

Annals of neurology, 2005-08, Vol.58 (2), p.322-326

2005

Volltextzugriff (PDF)

Chromosome 9p and 10q losses predict unfavorable outcome in low-grade gliomas

Neuro-oncology (Charlottesville, Va.), 2010-01, Vol.12 (1), p.2-6

2010

Volltextzugriff (PDF)

Radiotherapy for Glioblastoma in the Elderly

The New England journal of medicine, 2007-04, Vol.356 (15), p.1527-1535

2007

Volltextzugriff (PDF)

Influence of MDM2 SNP309 alone or in combination with the TP53 R72P polymorphism in oligodendroglial tumors

Brain research, 2008-03, Vol.1198, p.16-20

2008

Volltextzugriff (PDF)

Primary central nervous system lymphoma presenting with central neurogenic hyperventilation. A case report and review of the literature

Revue neurologique, 2005-10, Vol.161 (10), p.940-948

2005

Volltextzugriff (PDF)

Dynamic history of low-grade gliomas before and after temozolomide treatment

Annals of neurology, 2007-05, Vol.61 (5), p.484-490

2007

Volltextzugriff (PDF)

Clinical value of chromosome arms 19q and 11p losses in low-grade gliomas

Neuro-oncology (Charlottesville, Va.), 2014-03, Vol.16 (3), p.400-408

2014

Volltextzugriff (PDF)

Intracerebral injection of CpG oligonucleotide for patients with de novo glioblastoma—A phase II multicentric, randomised study

European journal of cancer (1990), 2017-03, Vol.73, p.30-37

2017

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(25)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(25)
Life Sciences & Biomedicine
(25)
Science & Technology
(25)
Female
(23)
Middle Aged
(23)
Adult
(22)
Neurosciences & Neurology
(22)
Clinical Neurology
(21)
Aged
(20)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Neurology
(15)
Brain Neoplasms - Pathology
(11)
Adolescent
(10)
Brain Neoplasms - Genetics
(10)
Prognosis
(9)
Tumors Of The Nervous System. Phacomatoses
(9)
Oncology
(8)
Retrospective Studies
(8)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas

Genetic markers predictive of chemosensitivity and outcome in gliomatosis cerebri

Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome

Gray matter involvement predicts chemosensitivity and prognosis in gliomatosis cerebri

Correlations between molecular profile and radiologic pattern in oligodendroglial tumors

Epidermal growth factor receptor extracellular domain mutations in primary glioblastoma

Supratentorial low-grade gliomas in older patients

Bevacizumab and irinotecan for recurrent oligodendroglial tumors

Ischemic stroke in patients with glioblastoma multiforme

TP53 codon 72 polymorphism is associated with age at onset of glioblastoma

Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study

Polymorphism in Sp1 recognition site of the EGF receptor gene promoter and risk of glioblastoma

EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastoma

Prognostic impact of molecular markers in a series of 220 primary glioblastomas

Gliomatosis cerebri : a review of 296 cases from the ANOCEF database and the literature

Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma

Multiple gliomas: clinical studies and pathophysiological hypothesis

Chromosome 1p loss: A favorable prognostic factor in low-grade gliomas

Chromosome 9p and 10q losses predict unfavorable outcome in low-grade gliomas

Radiotherapy for Glioblastoma in the Elderly

Influence of MDM2 SNP309 alone or in combination with the TP53 R72P polymorphism in oligodendroglial tumors

Primary central nervous system lymphoma presenting with central neurogenic hyperventilation. A case report and review of the literature

Dynamic history of low-grade gliomas before and after temozolomide treatment

Clinical value of chromosome arms 19q and 11p losses in low-grade gliomas

Intracerebral injection of CpG oligonucleotide for patients with de novo glioblastoma—A phase II multicentric, randomised study

Aktive Filter

Suchergebnisse filtern